Metformin Modulates Oxidative Stress in Murine Mesenchymal Stem Cells In Vitro and Alleviates Corticosteroid-Induced Inflammation and Impairment of Bone Formation.

IF 1.6 4区 医学 Q3 ORTHOPEDICS
Issei Shinohara, Yosuke Susuki, Masatoshi Murayama, Qi Gao, Mehmet Sertac Cekuc, Yasemin Sude Ergul, Mayu Morita, Alexa K Pius, Chao Ma, Simon Kwoon-Ho Chow, Stuart B Goodman
{"title":"Metformin Modulates Oxidative Stress in Murine Mesenchymal Stem Cells In Vitro and Alleviates Corticosteroid-Induced Inflammation and Impairment of Bone Formation.","authors":"Issei Shinohara, Yosuke Susuki, Masatoshi Murayama, Qi Gao, Mehmet Sertac Cekuc, Yasemin Sude Ergul, Mayu Morita, Alexa K Pius, Chao Ma, Simon Kwoon-Ho Chow, Stuart B Goodman","doi":"10.1177/15563316251351031","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Long-term use of corticosteroids is a known risk factor for various bone diseases. Corticosteroids disrupt the balance between oxidative and glycolytic energy metabolism, increase oxidative stress and reactive oxygen species (ROS) associated with prolongation of inflammation, cell apoptosis, deficits in mesenchymal stem cells (MSCs), and osteoclast differentiation. Metformin, a drug for diabetes, has antioxidant properties by inhibiting nicotinamide adenine dinucleotide phosphate oxidase, which promotes the production of ROS.</p><p><strong>Purpose: </strong>We sought to evaluate the effects of corticosteroid and metformin administration on MSCs in vitro.</p><p><strong>Methods: </strong>Primary bone marrow MSCs were collected from 20 mice. We evaluated prednisolone's effects on cell proliferation, oxidative stress, osteogenic differentiation, and mineralization, followed by metformin's effect on corticosteroid-induced reduction in bone formation. Metformin (1, 10, 100 µM) was tested with prednisolone 3 ng/mL. Cytokines were assessed by Luminex.</p><p><strong>Results: </strong>Prednisolone at 3 ng/mL significantly reduced cell proliferation, while 10 µM metformin restored it. Prednisolone increased oxidative stress and was reversed by metformin in a concentration-dependent manner, particularly at 100 µM. Osteogenic differentiation and mineralization were significantly impaired with prednisolone but improved with metformin at 10 and 100 µM. As for inflammatory cytokines, interleukin-1β (IL-1β) expression was increased by prednisolone administration and suppressed by metformin. Conversely, IL-6 and monocyte chemotactic protein-1 were suppressed by prednisolone.</p><p><strong>Conclusion: </strong>This in vitro study found that corticosteroid-associated decrease in osteogenic potential of murine MSCs was associated with elevated oxidative stress that can be alleviated by metformin; further studies are needed to validate these findings in vivo and with human-derived MSCs.</p>","PeriodicalId":35357,"journal":{"name":"Hss Journal","volume":" ","pages":"15563316251351031"},"PeriodicalIF":1.6000,"publicationDate":"2025-07-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12255654/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Hss Journal","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1177/15563316251351031","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"ORTHOPEDICS","Score":null,"Total":0}
引用次数: 0

Abstract

Background: Long-term use of corticosteroids is a known risk factor for various bone diseases. Corticosteroids disrupt the balance between oxidative and glycolytic energy metabolism, increase oxidative stress and reactive oxygen species (ROS) associated with prolongation of inflammation, cell apoptosis, deficits in mesenchymal stem cells (MSCs), and osteoclast differentiation. Metformin, a drug for diabetes, has antioxidant properties by inhibiting nicotinamide adenine dinucleotide phosphate oxidase, which promotes the production of ROS.

Purpose: We sought to evaluate the effects of corticosteroid and metformin administration on MSCs in vitro.

Methods: Primary bone marrow MSCs were collected from 20 mice. We evaluated prednisolone's effects on cell proliferation, oxidative stress, osteogenic differentiation, and mineralization, followed by metformin's effect on corticosteroid-induced reduction in bone formation. Metformin (1, 10, 100 µM) was tested with prednisolone 3 ng/mL. Cytokines were assessed by Luminex.

Results: Prednisolone at 3 ng/mL significantly reduced cell proliferation, while 10 µM metformin restored it. Prednisolone increased oxidative stress and was reversed by metformin in a concentration-dependent manner, particularly at 100 µM. Osteogenic differentiation and mineralization were significantly impaired with prednisolone but improved with metformin at 10 and 100 µM. As for inflammatory cytokines, interleukin-1β (IL-1β) expression was increased by prednisolone administration and suppressed by metformin. Conversely, IL-6 and monocyte chemotactic protein-1 were suppressed by prednisolone.

Conclusion: This in vitro study found that corticosteroid-associated decrease in osteogenic potential of murine MSCs was associated with elevated oxidative stress that can be alleviated by metformin; further studies are needed to validate these findings in vivo and with human-derived MSCs.

二甲双胍调节小鼠间充质干细胞的氧化应激,减轻皮质类固醇诱导的炎症和骨形成损伤。
背景:长期使用皮质类固醇是多种骨病的已知危险因素。皮质类固醇破坏氧化和糖酵解能量代谢之间的平衡,增加氧化应激和活性氧(ROS),与炎症延长、细胞凋亡、间充质干细胞(MSCs)缺陷和破骨细胞分化有关。二甲双胍是一种治疗糖尿病的药物,通过抑制烟酰胺腺嘌呤二核苷酸磷酸氧化酶而具有抗氧化特性,从而促进ROS的产生。目的:我们试图评估皮质类固醇和二甲双胍给药对体外MSCs的影响。方法:采集20只小鼠的原代骨髓间充质干细胞。我们评估了强的松龙对细胞增殖、氧化应激、成骨分化和矿化的影响,其次是二甲双胍对皮质类固醇诱导的骨形成减少的影响。用强的松龙3 ng/mL检测二甲双胍(1、10、100µM)。用Luminex检测细胞因子。结果:强的松龙浓度为3 ng/mL显著降低细胞增殖,而二甲双胍浓度为10µM可使细胞增殖恢复。强的松龙增加氧化应激,并以浓度依赖性的方式被二甲双胍逆转,特别是在100µM时。强的松龙明显损害成骨分化和矿化,但二甲双胍在10和100µM下可改善。炎症细胞因子方面,强的松龙组白细胞介素-1β (IL-1β)表达升高,二甲双胍抑制IL-1β表达。相反,IL-6和单核细胞趋化蛋白-1被强的松龙抑制。结论:本体外研究发现皮质类固醇相关的小鼠间充质干细胞成骨潜能降低与氧化应激升高有关,二甲双胍可缓解氧化应激升高;需要进一步的研究来验证这些发现在体内和人类来源的间充质干细胞。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Hss Journal
Hss Journal Medicine-Surgery
CiteScore
3.90
自引率
0.00%
发文量
42
期刊介绍: The HSS Journal is the Musculoskeletal Journal of Hospital for Special Surgery. The aim of the HSS Journal is to promote cutting edge research, clinical pathways, and state-of-the-art techniques that inform and facilitate the continuing education of the orthopaedic and musculoskeletal communities. HSS Journal publishes articles that offer contributions to the advancement of the knowledge of musculoskeletal diseases and encourages submission of manuscripts from all musculoskeletal disciplines.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信